IFRS 7 requires entities to disclose qualitative and quantitative information enabling users to evaluate the nature and extent of credit risk arising from financial instruments, and how management controls that risk. The objective is to give investors transparency over the entity's exposure to potential losses from counterparty default. Disclosures must cover both the maximum gross exposure and the credit quality profile of the portfolio.
Entities must disclose the gross carrying amount of financial assets that best represents maximum credit exposure — typically gross amortised cost for loans and receivables, or the full notional for undrawn commitments and financial guarantees. Separately, IFRS 7.36(b)–(c) require:
Collateral disclosures must distinguish between collateral the entity holds but cannot sell absent default and collateral it can sell or re-pledge regardless of default.
Entities must present a roll-forward of the loss allowance for each portfolio, split by ECL stage:
The reconciliation (IFRS 7.35H) shows opening balance, new originations, derecognitions, transfers between stages, remeasurements, write-offs, and closing balance. Write-off policy and contractual amounts outstanding on written-off assets still subject to enforcement are disclosed under IFRS 7.35L.
The entity must disclose the basis for determining whether credit risk has increased significantly since initial recognition, including:
This is an area of heightened regulatory scrutiny; vague descriptions of SICR criteria are frequently challenged in audit and regulatory reviews.
Entities must disclose credit quality information for financial assets neither past due nor impaired, typically by internal or external credit rating grade. Concentrations of credit risk require description of the shared characteristic defining each concentration (geography, sector, counterparty type) and the aggregate exposure amount.
An ageing analysis of financial assets past due but not impaired, plus separate disclosure of individually impaired assets and the factors considered, is required under IFRS 7.37.
Scenario: A bank holds corporate loan receivables of €50,000,000. ECL allowance movement at 31 December 20X3:
| Stage | Opening € | New Orig. € | Transfers € | Remeasure € | Write-offs € | Closing € |
|---|---|---|---|---|---|---|
| Stage 1 | 200,000 | 80,000 | (50,000) | 20,000 | — | 250,000 |
| Stage 2 | 150,000 | — | 50,000 | 30,000 | — | 230,000 |
| Stage 3 | 600,000 | — | — | 150,000 | (100,000) | 650,000 |
| Total | 950,000 | 80,000 | — | 200,000 | (100,000) | 1,130,000 |
| Account | Dr € | Cr € |
|---|---|---|
| Credit impairment loss (P&L) | 180,000 | |
| Loss allowance (contra-asset) | 180,000 |
The net book value disclosed on the balance sheet is €50,000,000 − €1,130,000 = €48,870,000, with the gross amount and allowance shown separately per IFRS 7.35J.